Tech Company Financing Transactions

Sherlock Biosciences Funding Round

Sherlock Biosciences closed a $80 million Series B funding round on 3/8/2022. Investors included Novalis LifeSciences, Albany Partners and Catalio Capital Management.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1 Bdwy.
Cambridge, MA 02142
USA

Phone

Undisclosed

Website

www.sherlock.bio

Email Address

[email protected]

Overview

Sherlock Biosciences is disrupting diagnostics. Sherlock Biosciences was founded on the belief that we can vastly improve human health and industrial testing worldwide. Diagnostic tests developed with our Engineering Biology platforms will help us deliver results faster, accurately and more affordably.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Feng Zhang

        

Chief Executive Officer

Rahul Dhanda

        

Chief Technical Officer

William Blake

        

Co-Founder

Omar Abudayyeh

        

Co-Founder

James Collins

        

Co-Founder

Todd Golub

        

Co-Founder

Jonathan Gootenberg

        

Co-Founder

Deborah Hung

        

Co-Founder

Pardis Sabeti

        

Co-Founder

David Walt

        

Browse more venture capital transactions:

Prev: 3/8/2022: Big Bold Health venture capital transaction
Next: 3/8/2022: Filtered venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary